Embera NeuroTherapeutics, Inc. announced the commencement of the first clinical trial evaluating its patent-pending drug combination for the treatment of cocaine addiction. The study is being conducted at the LSU Health Sciences Center's Psychopharmacology Research Clinic in Shreveport under the supervision of Dr. Anita Kablinger. (PRWeb Jan 2, 2008) Read the full story at http://www.prweb.com/releases/2008/01/prweb590551.htm
read more
